Mepcevi intravenous infusion 10mg, containing Vestronidase alpha (genetical recombination), is manufactured by Ultragenyx Japan. It is indicated for the treatment of non-neurological manifestations of Mucopolysaccharidosis VII (MPS VII; Sly syndrome), with a YJ code of 3959427A1020 and standard of 10mg 5mL x 1 bottle.
Mepcevi intravenous infusion 10mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).